Xu XX - Search Results

1

Disabled-2 inactivation is an early step in ovarian tumorigenicity.

Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. Fazili Z, et al. Among authors: xu xx. Oncogene. 1999 May 20;18(20):3104-13. doi: 10.1038/sj.onc.1202649. Oncogene. 1999. PMID: 10340382

2

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.

Xu XX, Yi T, Tang B, Lambeth JD. Xu XX, et al. Oncogene. 1998 Mar 26;16(12):1561-9. doi: 10.1038/sj.onc.1201678. Oncogene. 1998. PMID: 9569023

3

Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.

Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX. Sheng Z, et al. Among authors: xu xx. Oncogene. 2000 Oct 5;19(42):4847-54. doi: 10.1038/sj.onc.1203853. Oncogene. 2000. PMID: 11039902

4

Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).

Sheng Z, He J, Tuppen JA, Sun W, Fazili Z, Smith ER, Dong FB, Xu XX. Sheng Z, et al. Among authors: xu xx. Genomics. 2000 Dec 15;70(3):381-6. doi: 10.1006/geno.2000.6383. Genomics. 2000. PMID: 11161789

5

Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.

Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX. Yang DH, et al. Among authors: xu xx. Cancer. 2002 May 1;94(9):2380-92. doi: 10.1002/cncr.10497. Cancer. 2002. PMID: 12015763 Free article.

6

Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.

Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, Xu XX. Capo-Chichi CD, et al. Among authors: xu xx. Cancer. 2002 Oct 15;95(8):1802-15. doi: 10.1002/cncr.10870. Cancer. 2002. PMID: 12365030 Free article.

7

Cell cycle-dependent phosphorylation of Disabled-2 by cdc2.

He J, Xu J, Xu XX, Hall RA. He J, et al. Among authors: xu xx, xu j. Oncogene. 2003 Jul 17;22(29):4524-30. doi: 10.1038/sj.onc.1206767. Oncogene. 2003. PMID: 12881709

8

Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.

Capo-chichi CD, Roland IH, Vanderveer L, Bao R, Yamagata T, Hirai H, Cohen C, Hamilton TC, Godwin AK, Xu XX. Capo-chichi CD, et al. Among authors: xu xx. Cancer Res. 2003 Aug 15;63(16):4967-77. Cancer Res. 2003. PMID: 12941822

9

Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.

Yang WL, Roland IH, Godwin AK, Xu XX. Yang WL, et al. Among authors: xu xx. Oncogene. 2005 Dec 1;24(54):7991-8002. doi: 10.1038/sj.onc.1208943. Oncogene. 2005. PMID: 16044148

10

Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background.

Yang DH, Fazili Z, Smith ER, Cai KQ, Klein-Szanto A, Cohen C, Horowitz IR, Xu XX. Yang DH, et al. Among authors: xu xx. Am J Pathol. 2006 Jul;169(1):258-67. doi: 10.2353/ajpath.2006.060036. Am J Pathol. 2006. PMID: 16816378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters